{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:52:44Z","timestamp":1782935564554,"version":"3.54.5"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Atherosclerosis is a progressive inflammatory process involving the arteries of the body that is driven by cumulative exposure to low-density lipoprotein cholesterol and other lipoprotein particles. Although clinical manifestations typically occur later in life, the atherosclerotic process can begin decades earlier if lipid levels are not well controlled. Despite this, current prevention strategies do not adequately account for young adults at elevated lifetime cardiovascular risk. This review examined multiple studies evaluating statin use in young adults and found that many high-risk individuals are not identified or treated under current approaches. The studies demonstrate that 2013 and 2018 American College of Cardiology and American Heart Association guidelines excluded a substantial proportion of young adults who experienced myocardial infarction and may have benefited from therapy prior to their event. In addition to this, statin therapy remains underutilized even in individuals who meet guideline-based criteria. Recent guideline updates in 2026 have emphasized cumulative lifetime exposure to atherogenic lipoproteins and expanded consideration of statin therapy to younger populations, reflecting an important shift toward earlier identification and prevention of cardiovascular risk. This review examines contemporary evidence regarding statin therapy in young adults, identifies barriers to treatment, and discusses potential strategies to improve early cardiovascular prevention.<\/jats:p>","DOI":"10.1097\/crd.0000000000001385","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:10:56Z","timestamp":1782929456000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Implementation Gaps and Limitations of Statin Therapy in Young Adults: Bridging Guideline Recommendations and Real-World Practice"],"prefix":"10.1097","author":[{"given":"Christopher","family":"Annabi","sequence":"first","affiliation":[{"name":"New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"New York Medical College, Valhalla, NY"},{"name":"Department of Medicine, Westchester Medical Center, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"R1-20260701","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023.","volume":"406","year":"2025","journal-title":"Lancet (London, England)"},{"key":"R2-20260701","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative LDL cholesterol exposure during young adulthood and middle age and risk of cardiovascular events.","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R5-20260701","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL Variants and LDL-C-Lowering LDLR variants with risk of coronary heart disease.","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA"},{"key":"R6-20260701","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"R7-20260701","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement.","volume":"316","year":"2016","journal-title":"JAMA"},{"key":"R8-20260701","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"87","author":"Blumenthal","year":"2026","journal-title":"JACC"},{"key":"R9-20260701","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"R10-20260701","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2017.11.007","article-title":"Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry.","volume":"71","author":"Singh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R11-20260701","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2020.06.030","article-title":"Performance of guideline recommendations for prevention of myocardial infarction in young adults.","volume":"76","author":"Zeitouni","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R12-20260701","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jacc.2025.10.052","article-title":"Follow-up lipid testing and statin initiation among young adults in a U.S. Health Care System.","volume":"87","author":"Harrison","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"R13-20260701","doi-asserted-by":"crossref","first-page":"100492","DOI":"10.1016\/j.ajpc.2023.100492","article-title":"Disparities in statin prescription among patients with severe hypercholesterolemia in an integrated healthcare system.","volume":"14","author":"Jean-Marie","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"R14-20260701","doi-asserted-by":"crossref","first-page":"e020126","DOI":"10.1161\/JAHA.120.020126","article-title":"Treatment inertia in patients with familial hypercholesterolemia.","volume":"10","author":"Langer","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R16-20260701","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mayocpiqo.2019.01.003","article-title":"Risk of statin-induced hypertransaminasemia: a systematic review and meta-analysis of randomized controlled trials.","volume":"3","author":"Villani","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"R17-20260701","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3138\/canlivj-2023-0028","article-title":"Impact of statins in the liver: a bane or a boon?","volume":"7","author":"Zacharia","year":"2024","journal-title":"Can Liver J"},{"key":"R18-20260701","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects.","volume":"383","author":"Wood","year":"2020","journal-title":"N Engl J Med"},{"key":"R19-20260701","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jacc.2021.12.016","article-title":"Managing atherosclerotic cardiovascular risk in young adults: JACC state-of-the-art review.","volume":"79","author":"Stone","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R20-20260701","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jacc.2021.08.065","article-title":"Cost-effectiveness of lipid-lowering treatments in young adults.","volume":"78","author":"Kohli-Lynch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R21-20260701","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2023.09.817","article-title":"Primary prevention of subclinical atherosclerosis in young adults: JACC review topic of the week.","volume":"82","author":"Devesa","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R22-20260701","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1016\/j.jacl.2024.08.013","article-title":"Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the National Lipid Association.","volume":"18","author":"Soffer","year":"2024","journal-title":"J Clin Lipidol"},{"key":"R23-20260701","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.3390\/jcm14196713","article-title":"The association of lipoprotein(A) and coronary artery calcium in primary prevention patients-data from the STAR-Lp(A) study.","volume":"14","author":"Burzy\u0144ska","year":"2025","journal-title":"J Clin Med"},{"key":"R24-20260701","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamacardio.2021.2321","article-title":"Assessment of coronary artery calcium scoring to guide statin therapy allocation according to risk-enhancing factors: the multi-ethnic study of atherosclerosis.","volume":"6","author":"Patel","year":"2021","journal-title":"JAMA Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:10:59Z","timestamp":1782929459000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001385","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}